https://www.newsweek.com/who-pauses-hydroxychloroquine-trial-amid-safety-concerns-day-after-donald-trump-says-he-stopped-1506366
The
World Health Organization announced Monday that it was pausing an
ongoing trial of how hydroxychloroquine impacts hospitalized COVID-19
patients over safety concerns of the anti-malaria drug—medicine that
President Donald Trump said he was taking for at least two weeks.
A "temporary pause" of the WHO's hydroxychloroquine trial was instituted while "safety data is reviewed," said WHO Director General Tedros Adhanom Ghebreyesus.
A "temporary pause" of the WHO's hydroxychloroquine trial was instituted while "safety data is reviewed," said WHO Director General Tedros Adhanom Ghebreyesus.
The trial halt comes the day after Trump revealed in an interview
with Sinclair Broadcasting that he was no longer taking the unproven
coronavirus treatment and prevention method that health experts and
officials—including within the Trump administration—have warned not to
take outside hospital or clinical trial settings because of its
potentially deadly side effects.
No comments :
Post a Comment
ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.